Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial, (Nature Medicine, (2023), 10.1038/s41591-023-02668-y)
- Lindsay B. Kilburn*
- , Dong Anh Khuong-Quang
- , Jordan R. Hansford
- , Daniel Landi
- , Jasper van der Lugt
- , Sarah E.S. Leary
- , Pablo Hernáiz Driever
- , Simon Bailey
- , Sébastien Perreault
- , Geoffrey McCowage
- , Angela J. Waanders
- , David S. Ziegler
- , Olaf Witt
- , Patricia A. Baxter
- , Hyoung Jin Kang
- , Timothy E. Hassall
- , Jung Woo Han
- , Darren Hargrave
- , Andrea T. Franson
- , Michal Yalon Oren
*Corresponding author for this work
- Children’s National Hospital
- Children’s Cancer Centre
- Royal Children's Hospital Melbourne
- Michael Rice Centre for Haematology and Oncology
- Women's and Children's Hospital Adelaide
- Adelaide University
- Duke University
- Princess Máxima Center for Pediatric Oncology
- Cancer and Blood Disorders Center
- Seattle Children’s
- corporate member of Freie Universität Berlin and Humboldt-Universität Berlin
- Charité – Universitätsmedizin Berlin
- Newcastle University
- University of Montreal
- Sydney Children’s Hospitals Network
- Children's Memorial Hospital
- Kids Cancer Centre
- Sydney Children's Hospital
- University of New South Wales
- School of Clinical Medicine
- Hopp Children´s Cancer Center Heidelberg (KiTZ)
- Clinical Cooperation Unit
- German Cancer Research Center
- Department of Pediatric Oncology
- Heidelberg University
- Baylor College of Medicine
- Department of Pediatrics
- Seoul National University
- Children’s Health Queensland
- Yonsei University
- University College London
- University of Michigan, Ann Arbor
- Pediatric Hemato-Oncology
- Sheba Medical Center at Tel Hashomer
- Department of Pediatrics
- Ctr. Hosp. Universitaire de Quebec
- Division of Allergy Immunology
- The Children's Hospital of Philadelphia
- Washington University St. Louis
- McGill University
- Department of Pediatric and Adolescent Oncology and Hematology
- Telethon Institute for Child Health Research
- Department of Oncology
- University of Zurich
- University of Utah
- New York University
- Pediatric Neuro-Oncology
- Dana-Farber Cancer Institute
- Department of Hematology & amp; Oncology
- General Directorate Rambam Health Care Campus
- Haematology/Oncology Service
- KK Women's and Children's Hospital
- Department of Neurology
- University of California at San Francisco
- Day One Biopharmaceuticals, Inc.
- Division of Neurology
- Pediatric and Adolescent Department
- University of Copenhagen
- University of New South Wales
Research output: Contribution to journal › Comment/debate
3
Scopus
citations